Page 4 - High Acuity News Today

StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a report issued on Friday morning. The firm issued a buy rating on the health services provider’s stock. A number of other equities analysts have also commented on the stock. Cantor Fitzgerald increased their price target on shares of Amedisys from $100.00 to […]

Amedisys, Inc. (NASDAQ:AMED – Get Free Report) has earned a consensus recommendation of “Hold” from the eleven analysts that are presently covering the firm, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that […]

USPI saw "midteens" growth in total joint replacements at its ASCs in the third quarter of 2022. This growth was driven by the addition of 6 centers focused on

Quantinno Capital Management LP bought a new position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 15,326 shares of the health services provider’s stock, valued at approximately $1,401,000. Other large investors have also […]

State of New Jersey Common Pension Fund D lifted its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 23.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,553 shares of the health services provider’s stock after purchasing […]

Mackenzie Financial Corp decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 9.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 942,657 shares of the health services provider’s stock after selling 98,923 shares during the period. Mackenzie […]

Mackenzie Financial Corp cut its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 9.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 942,657 shares of the health services provider’s stock after selling 98,923 shares during the quarter. Mackenzie Financial […]

Mackenzie Financial Corp decreased its holdings in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 9.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 942,657 shares of the health services provider’s stock after selling 98,923 shares during the quarter. Mackenzie […]

StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report released on Monday. The brokerage issued a buy rating on the health services provider’s stock. Several other equities analysts have also recently weighed in on AMED. TD Cowen increased their price target on Amedisys from $84.00 to $101.00 and gave […]

Oppenheimer Asset Management Inc. trimmed its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 1.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 69,083 shares of the health services provider’s stock after selling 1,195 shares […]